Skip to main content
Fig. 5 | Allergy, Asthma & Clinical Immunology

Fig. 5

From: Predictive significance of arachidonate 15-lipoxygenase for eosinophilic chronic rhinosinusitis with nasal polyps

Fig. 5

Comparison of self-assessed symptom scores (VAS) between the high combination level group and the low combination level group divided according to the predictive cut-off value. a nasal obstruction score, b rhinorrhea score, c olfaction score, d facial pain or headache score, and e total VAS score. VAS visual analogue scale. The combination represents arachidonate 15-lipoxygenase with blood eosinophils

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us